TY - JOUR
T1 - Pediatric Respiratory and Systemic Effects of Chronic Air Pollution Exposure
T2 - Nose, Lung, Heart, and Brain Pathology
AU - Calderón-Garcidueñas, Lilian
AU - Franco-Lira, Maricela
AU - Torres-Jardón, Ricardo
AU - Henriquez-Roldán, Carlos
AU - Barragán-Mejía, Gerardo
AU - Valencia-Salazar, Gildardo
AU - Gonzaléz-Maciel, Angelica
AU - Reynoso-Robles, Rafael
AU - Villarreal-Calderón, Rafael
AU - Reed, William
N1 - Funding Information:
Grant support was provided by 1KO1 NS046410-01A1, 1R21-ES013293-01A1, and US EPA CR829522, National Science Foundation 0346458, and the Montana Board of Research and Commercialization Technology Grant No 04-06, #5 P20 RR015583 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)
PY - 2007/1
Y1 - 2007/1
N2 - Exposures to particulate matter and gaseous air pollutants have been associated with respiratory tract inflammation, disruption of the nasal respiratory and olfactory barriers, systemic inflammation, production of mediators of inflammation capable of reaching the brain and systemic circulation of particulate matter. Mexico City (MC) residents are exposed to significant amounts of ozone, particulate matter and associated lipopolysaccharides. MC dogs exhibit brain inflammation and an acceleration of Alzheimer's-like pathology, suggesting that the brain is adversely affected by air pollutants. MC children, adolescents and adults have a significant upregulation of cyclooxygenase-2 (COX2) and interleukin-1β (IL-1β) in olfactory bulb and frontal cortex, as well as neuronal and astrocytic accumulation of the 42 amino acid form of β-amyloid peptide (Aβ42), including diffuse amyloid plaques in frontal cortex. The pathogenesis of Alzheimer's disease (AD) is characterized by brain inflammation and the accumulation of Aβ42, which precede the appearance of neuritic plaques and neurofibrillary tangles, the pathological hallmarks of AD. Our findings of nasal barrier disruption, systemic inflammation, and the upregulation of COX2 and IL-1β expression and Aβ42 accumulation in brain suggests that sustained exposures to significant concentrations of air pollutants such as particulate matter could be a risk factor for AD and other neurodegenerative diseases.
AB - Exposures to particulate matter and gaseous air pollutants have been associated with respiratory tract inflammation, disruption of the nasal respiratory and olfactory barriers, systemic inflammation, production of mediators of inflammation capable of reaching the brain and systemic circulation of particulate matter. Mexico City (MC) residents are exposed to significant amounts of ozone, particulate matter and associated lipopolysaccharides. MC dogs exhibit brain inflammation and an acceleration of Alzheimer's-like pathology, suggesting that the brain is adversely affected by air pollutants. MC children, adolescents and adults have a significant upregulation of cyclooxygenase-2 (COX2) and interleukin-1β (IL-1β) in olfactory bulb and frontal cortex, as well as neuronal and astrocytic accumulation of the 42 amino acid form of β-amyloid peptide (Aβ42), including diffuse amyloid plaques in frontal cortex. The pathogenesis of Alzheimer's disease (AD) is characterized by brain inflammation and the accumulation of Aβ42, which precede the appearance of neuritic plaques and neurofibrillary tangles, the pathological hallmarks of AD. Our findings of nasal barrier disruption, systemic inflammation, and the upregulation of COX2 and IL-1β expression and Aβ42 accumulation in brain suggests that sustained exposures to significant concentrations of air pollutants such as particulate matter could be a risk factor for AD and other neurodegenerative diseases.
KW - Alzheimer disease early risk factors
KW - Children
KW - air pollution
KW - beta-amyloid
KW - nasal epithelial barrier
KW - particulate matter
KW - systemic inflammation
UR - http://www.scopus.com/inward/record.url?scp=33847257762&partnerID=8YFLogxK
U2 - 10.1080/01926230601059985
DO - 10.1080/01926230601059985
M3 - Article
C2 - 17325984
AN - SCOPUS:33847257762
SN - 0192-6233
VL - 35
SP - 154
EP - 162
JO - Toxicologic Pathology
JF - Toxicologic Pathology
IS - 1
ER -